Header Logo

Connection

Shabir Madhi to Half-Life

Back to Details
This is a "connection" page, showing publications Shabir Madhi has written about Half-Life.
Shabir Madhi
Connection Strength
0,245
Half-Life
  1. A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants. J Infect Dis. 2025 Mar 17; 231(3):e478-e487.
    View in: PubMed
    Score: 0,245
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.